These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 3340645)
21. Therapy of homozygous type IIA familial hypercholesterolemia using special on line plasma filter pheresis. Siami G; Hakim R Prog Clin Biol Res; 1990; 337():209-12. PubMed ID: 2352978 [No Abstract] [Full Text] [Related]
22. Comparison of selectivity of LDL removal by double filtration and dextran-sulfate cellulose column plasmapheresis. Homma Y; Mikami Y; Tamachi H; Nakaya N; Nakamura H; Araki G; Goto Y Atherosclerosis; 1986 Apr; 60(1):23-7. PubMed ID: 2423096 [TBL] [Abstract][Full Text] [Related]
23. Comparison of different LDL apheresis methods. Julius U; Frind A; Tselmin S; Kopprasch S; Poberschin I; Siegert G Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):629-39. PubMed ID: 18510481 [TBL] [Abstract][Full Text] [Related]
24. Plasma-exchange therapy of homozygous familial hypercholesterolemia. King ME; Breslow JL; Lees RS N Engl J Med; 1980 Jun; 302(26):1457-9. PubMed ID: 7374711 [No Abstract] [Full Text] [Related]
25. Apheresis technologies for prevention and regression of atherosclerosis: clinical results. Bambauer R; Schneidewind JM; Latza R ASAIO J; 1999; 45(5):403-7. PubMed ID: 10503615 [TBL] [Abstract][Full Text] [Related]
30. [An apheresis method in treatment of familial hypercholesterolemia]. Derfler K Wien Klin Wochenschr; 2000 Jan; 112(2):49-51. PubMed ID: 10703150 [No Abstract] [Full Text] [Related]
31. [Extracorporeal elimination of LDL-cholesterol in the treatment of hypercholesterolemia: indications and methods]. Bláha V; Havel E; Zadák Z; Pidrman V; Bláha M; Kalinová M Vnitr Lek; 1995 Oct; 41(10):724-9. PubMed ID: 8578708 [TBL] [Abstract][Full Text] [Related]
32. [Plasma exchange therapy in a patient with familial hypercholesteremia and generalized arteriosclerosis]. Schrecker O; Thies K; Schlierf G Internist (Berl); 1984 Sep; 25(9):574-6. PubMed ID: 6386739 [No Abstract] [Full Text] [Related]
33. A double mutant [N543H+2393del9] allele in the LDL receptor gene in familial hypercholesterolemia: effect on plasma cholesterol levels and cardiovascular disease. Castillo S; Reyes G; Tejedor D; Mozas P; Suarez Y; Lasuncion MA; Cenarro A; Civeira F; Alonso R; Mata P; Pocovi M; Hum Mutat; 2002 Dec; 20(6):477. PubMed ID: 12442279 [TBL] [Abstract][Full Text] [Related]
34. Extracorporeal treatment of hypercholesterolaemia. Olbricht CJ Nephrol Dial Transplant; 1993; 8(9):814-20. PubMed ID: 8255513 [TBL] [Abstract][Full Text] [Related]
35. Diet only and diet plus simvastatin in the treatment of heterozygous familial hypercholesterolemia in childhood. Stefanutti C; Lucani G; Vivenzio A; Di Giacomo S Drugs Exp Clin Res; 1999; 25(1):23-8. PubMed ID: 10337501 [TBL] [Abstract][Full Text] [Related]
36. Removal of low density lipoproteins (LDL) from plasma: the state of the art. Klinkmann H; Behm E; Ivanovich P Int J Artif Organs; 1989 Apr; 12(4):207-10. PubMed ID: 2656536 [No Abstract] [Full Text] [Related]
38. Influence of HDL cholesterol on preclinical carotid atherosclerosis in familial hypercholesterolemia. Junyent M; Cofán M; Núñez I; Gilabert R; Zambón D; Ros E Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1107-13. PubMed ID: 16556855 [TBL] [Abstract][Full Text] [Related]
39. Effects of plant stanol and sterol esters on serum phytosterols in a family with familial hypercholesterolemia including a homozygous subject. Ketomaki A; Gylling H; Miettinen TA J Lab Clin Med; 2004 Apr; 143(4):255-62. PubMed ID: 15085084 [TBL] [Abstract][Full Text] [Related]
40. Extracorporeal LDL elimination with immunabsorption or heparin precipitation: a comparison in 10 patients. Richter WO; Vierneisel K; Schwandt P Beitr Infusionsther; 1988; 23():127-31. PubMed ID: 2484766 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]